المؤلفون: Garutti M., Griguolo G., Botticelli A., Buzzatti G., De Angelis C., Gerratana L., Molinelli C., Adamo V., Bianchini G., Biganzoli L., Curigliano G., De Laurentiis M., Fabi A., Frassoldati A., Gennari A., Marchio C., Perrone F., Viale G., Zamagni C., Zambelli A., Del Mastro L., De Placido S., Guarneri V., Marchetti P., Puglisi F.

المساهمون: Garutti, M., Griguolo, G., Botticelli, A., Buzzatti, G., De Angelis, C., Gerratana, L., Molinelli, C., Adamo, V., Bianchini, G., Biganzoli, L., Curigliano, G., De Laurentiis, M., Fabi, A., Frassoldati, A., Gennari, A., Marchio, C., Perrone, F., Viale, G., Zamagni, C., Zambelli, A., Del Mastro, L., De Placido, S., Guarneri, V., Marchetti, P., Puglisi, F.

مصطلحات موضوعية: adjuvant, breast cancer, chemotherapy, consensu, ctDNA, endocrine therapy, genomic signature, hormone receptor, risk of relapse, TNM

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35454806; info:eu-repo/semantics/altIdentifier/wos/WOS:000786809500001; volume:14; firstpage:-; lastpage:-; numberofpages:17; journal:CANCERS; http://hdl.handle.net/11567/1081202Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85127791037

الإتاحة: https://doi.org/10.3390/cancers14081898Test
http://hdl.handle.net/11567/1081202Test

المؤلفون: Schettini F., Giuliano M., Lambertini M., Bartsch R., Pinato D. J., Onesti C. E., Harbeck N., Luftner D., Rottey S., van Dam P. A., Zaman K., Mustacchi G., Gligorov J., Awada A., Campone M., Wildiers H., Gennari A., Tjan-heijnen V. C. G., Cortes J., Locci M., Paris I., Mastro L. D., De Placido S., Martin M., Jerusalem G., Venturini S., Curigliano G., Generali D.

المساهمون: F. Schettini, M. Giuliano, M. Lambertini, R. Bartsch, D.J. Pinato, C.E. Onesti, N. Harbeck, D. Luftner, S. Rottey, P.A. van Dam, K. Zaman, G. Mustacchi, J. Gligorov, A. Awada, M. Campone, H. Wildier, A. Gennari, V.C.G. Tjan-heijnen, J. Corte, M. Locci, I. Pari, L.D. Mastro, S. De Placido, M. Martin, G. Jerusalem, S. Venturini, G. Curigliano, D. Generali

مصطلحات موضوعية: Anthracycline, Breast cancer, Hormone receptor, Metastatic, Non‐pegylated liposomal doxorubicin, Triple negative, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34503231; info:eu-repo/semantics/altIdentifier/wos/WOS:000694139700001; volume:13; issue:17; firstpage:1; lastpage:17; numberofpages:17; journal:CANCERS; http://hdl.handle.net/2434/910132Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85114083798

الإتاحة: https://doi.org/10.3390/cancers13174421Test
http://hdl.handle.net/2434/910132Test

المؤلفون: Garutti M., Griguolo G., Botticelli A., Buzzatti G., De Angelis C., Gerratana L., Molinelli C., Adamo V., Bianchini G., Biganzoli L., Curigliano G., De Laurentiis M., Fabi A., Frassoldati A., Gennari A., Marchio C., Perrone F., Viale G., Zamagni C., Zambelli A., Del Mastro L., De Placido S., Guarneri V., Marchetti P., Puglisi F.

المساهمون: Garutti, M., Griguolo, G., Botticelli, A., Buzzatti, G., De Angelis, C., Gerratana, L., Molinelli, C., Adamo, V., Bianchini, G., Biganzoli, L., Curigliano, G., De Laurentiis, M., Fabi, A., Frassoldati, A., Gennari, A., Marchio, C., Perrone, F., Viale, G., Zamagni, C., Zambelli, A., Del Mastro, L., De Placido, S., Guarneri, V., Marchetti, P., Puglisi, F.

مصطلحات موضوعية: adjuvant, breast cancer, chemotherapy, consensus, ctDNA, endocrine therapy, genomic signature, hormone receptors, risk of relapse, TNM

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000786809500001; volume:14; issue:8; journal:CANCERS; https://hdl.handle.net/20.500.11768/161816Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85127791037

الإتاحة: https://doi.org/20.500.11768/16181610.3390/cancers14081898Test
https://hdl.handle.net/20.500.11768/161816Test

المؤلفون: Schettini F., Giuliano M., Lambertini M., Bartsch R., Pinato D. J., Onesti C. E., Harbeck N., Luftner D., Rottey S., van Dam P. A., Zaman K., Mustacchi G., Gligorov J., Awada A., Campone M., Wildiers H., Gennari A., Tjan-heijnen V. C. G., Cortes J., Locci M., Paris I., Del Mastro L., De Placido S., Martin M., Jerusalem G., Venturini S., Curigliano G., Generali D.

المساهمون: Schettini, F., Giuliano, M., Lambertini, M., Bartsch, R., Pinato, D. J., Onesti, C. E., Harbeck, N., Luftner, D., Rottey, S., van Dam, P. A., Zaman, K., Mustacchi, G., Gligorov, J., Awada, A., Campone, M., Wildiers, H., Gennari, A., Tjan-heijnen, V. C. G., Cortes, J., Locci, M., Paris, I., Del Mastro, L., De Placido, S., Martin, M., Jerusalem, G., Venturini, S., Curigliano, G., Generali, D.

مصطلحات موضوعية: Anthracycline, Breast cancer, Hormone receptor, Metastatic, Non‐pegylated liposomal doxorubicin, Triple negative

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34503231; info:eu-repo/semantics/altIdentifier/wos/WOS:000694139700001; volume:13; firstpage:4421; lastpage:4437; numberofpages:17; journal:CANCERS; http://hdl.handle.net/11567/1055832Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85114083798

الإتاحة: https://doi.org/10.3390/cancers13174421Test
http://hdl.handle.net/11567/1055832Test

المؤلفون: Venturini S., Generali D.

المساهمون: Schettini, F., Giuliano, M., Giudici, F., Conte, B., De Placido, P., Venturini, Sergio, Rognoni, C., Leo, A. D., Locci, M., Jerusalem, G., Mastro, L. D., Puglisi, F., Conte, P., De Laurentiis, M., Pusztai, L., Rimawi, M. F., Schiff, R., Arpino, G., De Placido, S., Prat, A., Generali, Daniele

مصطلحات موضوعية: endocrine therapy, hormone receptor, meta-analysis, metastatic breast cancer, systematic review, Settore SECS-S/01 - STATISTICA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33810205; info:eu-repo/semantics/altIdentifier/wos/WOS:000634332900001; volume:13; issue:6; firstpage:1; lastpage:21; numberofpages:21; issueyear:2021; journal:CANCERS; https://hdl.handle.net/10807/238857Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85102728266

الإتاحة: https://doi.org/10.3390/cancers13061458Test
https://hdl.handle.net/10807/238857Test

المؤلفون: Gennari A., Paris I., Venturini S., Generali D.

المساهمون: Schettini, F., Giuliano, M., Lambertini, M., Bartsch, R., Pinato, D. J., Onesti, C. E., Harbeck, N., Luftner, D., Rottey, S., van Dam, P. A., Zaman, K., Mustacchi, G., Gligorov, J., Awada, A., Campone, M., Wildiers, H., Gennari, Alessandro, Tjan-heijnen, V. C. G., Cortes, J., Locci, M., Paris, Ida, Mastro, L. D., De Placido, S., Martin, M., Jerusalem, G., Venturini, Sergio, Curigliano, G., Generali, Daniele

مصطلحات موضوعية: anthracyclines, breast cancer, hormone receptor, metastatic, non-pegylated liposomal doxorubicin, triple negative, Settore SECS-S/01 - STATISTICA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34503231; info:eu-repo/semantics/altIdentifier/wos/WOS:000694139700001; volume:13; issue:17; firstpage:4421; lastpage:N/A; numberofpages:17; issueyear:2021; journal:CANCERS; https://hdl.handle.net/10807/238856Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85114083798

الإتاحة: https://doi.org/10.3390/cancers13174421Test
https://hdl.handle.net/10807/238856Test